Retia 2
Ophthalmoscope, Laser, Scanning. 510(k) K180293, from Centervue S.P.A. (Padova, IT). Product code MYC, class 2.
As of Nov 20, 2026, K180293 is an FDA 510(k) held by Centervue S.P.A., substantially equivalent on May 30, 2018 after 118 days, with no recalls tied to it in FDA's recall database.
- Review time: 118 days
- Recalls: 0
The CenterVue RETIA 2 is a confocal scanning ophthalmoscope indicated for infrared and auto-fluorescence imaging of a human retina with or without the use of a mydriatic agent.
- EidonK142047 · Centervue S.P.A. · Nov 12, 2014
- Adaptive Optics Scanning Laser Ophthalmoscope (Mona IV)K261740 · Robotrak Technologies Co., Ltd. · Oct 27, 2026
- Kowa FM-600K261255 · Kowa Company, Ltd. Chofu Factory · Sep 11, 2026
- OcuMet Beacon (OCUB100)K241931 · Ocusciences, Inc. · Apr 22, 2025
- Maia (Ahmacme001)K243504 · Centervue S.P.A. · Mar 17, 2025
- DRSplusK213705 · Centervue S.P.A. · Dec 21, 2021
- Eidon Fa, Eidon, Eidon Af, Eidon UwflK211328 · Centervue S.P.A. · Aug 19, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 1, 2018
- Review panel
- Ophthalmic
- Regulation
- 21 CFR 886.1570
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files